| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| Gkap1 | Rnf157 | ENSRNOP00000075132 | ENSRNOP00000064600 | G kinase-anchoring protein 1; Regulates insulin-dependent IRS1 tyrosine phosphorylation in adipocytes by modulating the availability of IRS1 to IR tyrosine kinase. Its association with IRS1 is required for insulin-induced translocation of SLC2A4 to the cell membrane. Involved in TNF-induced impairment of insulin-dependent IRS1 tyrosine phosphorylation. | E3 ubiquitin ligase Rnf157; E3 ubiquitin ligase that ubiquitinates APBB1 for its degradation by the proteasome and thus prevents apoptosis and promotes survival of neurons (By similarity). Has a dual role in neurons as it is also required for dendrite growth and maintenance for which its ligase activity is not critical (By similarity). May act as a scaffold molecule to regulate this process (By similarity). Acts as a downstream effector of the interconnected PI3K and MAPK signaling pathways and thus participates in the regulation of the cell cycle (By similarity). | 0.697 |
| Gkap1 | Slc29a4 | ENSRNOP00000075132 | ENSRNOP00000001477 | G kinase-anchoring protein 1; Regulates insulin-dependent IRS1 tyrosine phosphorylation in adipocytes by modulating the availability of IRS1 to IR tyrosine kinase. Its association with IRS1 is required for insulin-induced translocation of SLC2A4 to the cell membrane. Involved in TNF-induced impairment of insulin-dependent IRS1 tyrosine phosphorylation. | Solute carrier family 29 member 4. | 0.623 |
| Mfsd10 | Mfsd14a | ENSRNOP00000017386 | ENSRNOP00000020907 | Major facilitator superfamily domain-containing 10. | Hippocampus abundant gene transcript 1 (Predicted). | 0.457 |
| Mfsd10 | Mfsd9 | ENSRNOP00000017386 | ENSRNOP00000032132 | Major facilitator superfamily domain-containing 10. | Major facilitator superfamily domain-containing 9. | 0.679 |
| Mfsd10 | Slc29a4 | ENSRNOP00000017386 | ENSRNOP00000001477 | Major facilitator superfamily domain-containing 10. | Solute carrier family 29 member 4. | 0.524 |
| Mfsd10 | Slc46a2 | ENSRNOP00000017386 | ENSRNOP00000023588 | Major facilitator superfamily domain-containing 10. | Thymic stromal cotransporter (Predicted). | 0.711 |
| Mfsd14a | Mfsd10 | ENSRNOP00000020907 | ENSRNOP00000017386 | Hippocampus abundant gene transcript 1 (Predicted). | Major facilitator superfamily domain-containing 10. | 0.457 |
| Mfsd14a | Mfsd9 | ENSRNOP00000020907 | ENSRNOP00000032132 | Hippocampus abundant gene transcript 1 (Predicted). | Major facilitator superfamily domain-containing 9. | 0.476 |
| Mfsd14a | Slc29a4 | ENSRNOP00000020907 | ENSRNOP00000001477 | Hippocampus abundant gene transcript 1 (Predicted). | Solute carrier family 29 member 4. | 0.517 |
| Mfsd14a | Slc46a2 | ENSRNOP00000020907 | ENSRNOP00000023588 | Hippocampus abundant gene transcript 1 (Predicted). | Thymic stromal cotransporter (Predicted). | 0.647 |
| Mfsd9 | Mfsd10 | ENSRNOP00000032132 | ENSRNOP00000017386 | Major facilitator superfamily domain-containing 9. | Major facilitator superfamily domain-containing 10. | 0.679 |
| Mfsd9 | Mfsd14a | ENSRNOP00000032132 | ENSRNOP00000020907 | Major facilitator superfamily domain-containing 9. | Hippocampus abundant gene transcript 1 (Predicted). | 0.476 |
| Mfsd9 | Slc29a4 | ENSRNOP00000032132 | ENSRNOP00000001477 | Major facilitator superfamily domain-containing 9. | Solute carrier family 29 member 4. | 0.602 |
| Mfsd9 | Slc46a2 | ENSRNOP00000032132 | ENSRNOP00000023588 | Major facilitator superfamily domain-containing 9. | Thymic stromal cotransporter (Predicted). | 0.701 |
| Rnf157 | Gkap1 | ENSRNOP00000064600 | ENSRNOP00000075132 | E3 ubiquitin ligase Rnf157; E3 ubiquitin ligase that ubiquitinates APBB1 for its degradation by the proteasome and thus prevents apoptosis and promotes survival of neurons (By similarity). Has a dual role in neurons as it is also required for dendrite growth and maintenance for which its ligase activity is not critical (By similarity). May act as a scaffold molecule to regulate this process (By similarity). Acts as a downstream effector of the interconnected PI3K and MAPK signaling pathways and thus participates in the regulation of the cell cycle (By similarity). | G kinase-anchoring protein 1; Regulates insulin-dependent IRS1 tyrosine phosphorylation in adipocytes by modulating the availability of IRS1 to IR tyrosine kinase. Its association with IRS1 is required for insulin-induced translocation of SLC2A4 to the cell membrane. Involved in TNF-induced impairment of insulin-dependent IRS1 tyrosine phosphorylation. | 0.697 |
| Rnf157 | Slc29a4 | ENSRNOP00000064600 | ENSRNOP00000001477 | E3 ubiquitin ligase Rnf157; E3 ubiquitin ligase that ubiquitinates APBB1 for its degradation by the proteasome and thus prevents apoptosis and promotes survival of neurons (By similarity). Has a dual role in neurons as it is also required for dendrite growth and maintenance for which its ligase activity is not critical (By similarity). May act as a scaffold molecule to regulate this process (By similarity). Acts as a downstream effector of the interconnected PI3K and MAPK signaling pathways and thus participates in the regulation of the cell cycle (By similarity). | Solute carrier family 29 member 4. | 0.571 |
| Slc18a2 | Slc29a4 | ENSRNOP00000011983 | ENSRNOP00000001477 | Synaptic vesicular amine transporter; Involved in the ATP-dependent vesicular transport of biogenic amine neurotransmitters. Pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synaptic vesicles. Requisite for vesicular amine storage prior to secretion via exocytosis; Belongs to the major facilitator superfamily. Vesicular transporter family. | Solute carrier family 29 member 4. | 0.541 |
| Slc28a1 | Slc29a4 | ENSRNOP00000070095 | ENSRNOP00000001477 | Sodium/nucleoside cotransporter 1; Sodium-dependent and pyrimidine-selective transporter. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). Transports uridine, cytidine, thymidine, and nucleoside-derived drugs. Transports the antiviral pyrimidine nucleoside analogs 3'-azido-3'-deoxythymidine (AZT) and 2',3'- dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). | Solute carrier family 29 member 4. | 0.581 |
| Slc28a2 | Slc29a4 | ENSRNOP00000024658 | ENSRNOP00000001477 | Sodium/nucleoside cotransporter 2; Sodium-dependent and purine-selective. Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine). Accepts purine, analogs of purine nucleosides and uridine, and exhibits high affinity for adenosine; Belongs to the concentrative nucleoside transporter (CNT) (TC 2.A.41) family. | Solute carrier family 29 member 4. | 0.545 |
| Slc28a3 | Slc29a4 | ENSRNOP00000025745 | ENSRNOP00000001477 | Solute carrier family 28 member 3; Sodium-dependent, pyrimidine- and purine-selective. Involved in the homeostasis of endogenous nucleosides. Exhibits the transport characteristics of the nucleoside transport system cib or N3 subtype (N3/cib) (with marked transport of both thymidine and inosine). Employs a 2:1 sodium/nucleoside ratio. Also able to transport gemcitabine, 3'- azido-3'-deoxythymidine (AZT), ribavirin and 3-deazauridine (By similarity). | Solute carrier family 29 member 4. | 0.692 |